Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
2.61
0.00 (0.00%)
USD |
OTCM |
Feb 19, 16:00
Shanghai Fosun Pharmaceutical EPS Diluted (Quarterly) : 0.0435 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sinovac Biotech Ltd. | -- |
| CASI Pharmaceuticals, Inc. | -0.6781 |
| Zai Lab Ltd. | -0.3267 |
| WuXi Biologics (Cayman), Inc. | -- |
| Viva Biotech Holdings | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 133.55M |
| Revenue (Quarterly) | 1.380B |
| Total Expenses (Quarterly) | 1.265B |
| Enterprise Value | 12.06B |
| Gross Profit Margin (Quarterly) | 48.35% |
| Profit Margin (Quarterly) | 9.68% |
| Earnings Yield | 6.59% |
| Operating Earnings Yield | 4.00% |
| Normalized Earnings Yield | 7.126 |